Home » Topics » Articles » Insight

Insight
RSS

FDA Submissions, Approvals And Other Actions: September 2001

Oct. 15, 2001

Venture Capital And Corporate Investments In Biotechnology Companies: September 2001

Oct. 8, 2001

Analyst: Genomics Reaches 'Productivity Inflection Point'

Oct. 8, 2001

Public Financing of Biotechnology: September 2001

Oct. 8, 2001

Other Financings Of Public Biotechnology Companies: September 2001

Oct. 8, 2001

Biological Terrorism: Worth Fighting, But Not Investing

Oct. 1, 2001

Biotech Mergers And Acquisitions: July 19 Sept. 27, 2001#

Oct. 1, 2001

ImClone's True Grit: From Near Bankruptcy To $2B Deal

Sep. 24, 2001

Biotech - Big Pharma Collaborations: New Agreements June 27 Sept. 18, 2001

Sep. 24, 2001

Manufacturing, Marketing And Distribution Agreements Between Biotechnology And Pharmaceutical Companies: June 27 Sept. 18, 2001

Sep. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...